Procter & Gamble Stock Performance
Procter & Gamble shares traded at $146.66, reflecting a modest daily gain of 0.09%, per SID market data. Over the trailing one-month period, the stock gained 1.47%, though the three-month return stands at negative 2.52%, indicating recent choppiness in price action. On a twelve-month basis, PG has returned 4.2%, underperforming broader equity indices. The stock currently sits just above its 50-day moving average of $146.26 but remains below its 200-day moving average of $149.81, according to Massive/Polygon technical data. The 14-day relative strength index reads 54.0, placing PG in neutral momentum territory. Average daily volume stands at approximately 8.54 million shares. With a beta of 0.382, the stock exhibits significantly lower volatility than the broader market, consistent with its Consumer Defensive sector classification and its $328.9 billion market capitalization.
Procter & Gamble Valuation Analysis
Procter & Gamble currently trades at a price-to-earnings ratio of 20.46, per SID market data, positioning it within a moderate valuation range for a large-cap Consumer Defensive name. However, the PEG ratio of 3.90 suggests the stock's earnings growth rate may not fully justify its current multiple, as values above 1.0 generally indicate limited growth relative to price. The price-to-book ratio stands at 6.44, reflecting the significant premium the market assigns to PG's portfolio of established consumer brands and intangible assets, according to SEC filings. The company offers a dividend yield of approximately 2.97%, providing meaningful income to shareholders and reinforcing its status as a defensive holding. Taken together, these metrics indicate PG commands a valuation premium typical of blue-chip staples companies, though the elevated PEG ratio warrants monitoring against forward earnings trajectory expectations.
Smart Money Activity for PG
Procter & Gamble's composite smart money score stands at 51 out of 100, registering a neutral signal, per SID market data. Institutional positioning scores a perfect 25 out of 25, reflecting strong sustained ownership among large fund managers, according to 13F institutional filings. Dark pool activity scores 13.5 out of 25, indicating moderate off-exchange transaction volume. Congressional trading interest registers at 12.8 out of 25, showing middling legislative portfolio activity. Insider sentiment, however, scores 0.0 out of 25, the lowest possible mark in that category. According to SEC Form 4 filings, company insiders executed 20 transactions over the past 90 days, comprising 6 purchases and 14 sales. The disparity between insider sells and buys represents a roughly 2.3-to-1 sell-to-buy ratio. This divergence between robust institutional conviction and notable insider selling activity creates the mixed composite reading that defines PG's current neutral smart money positioning.
Procter & Gamble Earnings Outlook
Procter & Gamble has demonstrated a consistent pattern of modest earnings beats in its most recently reported quarters. According to company earnings reports, PG posted earnings per share of $1.59 against analyst estimates of $1.56 for the quarter reported on April 24, delivering a positive surprise of $0.03. In the subsequent quarter reported on July 29, the company earned $1.43 per share versus the $1.42 consensus, a $0.01 beat. These results reflect PG's ability to manage margins and volumes effectively. Looking ahead, analyst estimates project earnings of $1.57 per share for the upcoming April report and $1.42 for the following July period. The forward estimates suggest relatively stable sequential earnings expectations. The narrow magnitude of recent surprises indicates that analyst models closely track PG's operational performance, leaving limited room for significant upside or downside deviation from consensus.
Wall Street Analyst Ratings for PG
Recent Wall Street analyst activity on Procter & Gamble reflects a shift toward more cautious sentiment, per SID consensus data. On August 7, Argus Research downgraded PG from Buy to Hold, marking a notable change from one of the stock's previously supportive voices. On July 30, HSBC similarly downgraded the stock from Buy to Hold, compounding the negative ratings momentum. That same day, Citigroup maintained its Buy rating, providing a counterbalance. Earlier in July, JP Morgan reiterated its Overweight rating on July 16, while Barclays maintained an Equal-Weight stance on July 21, according to Wall Street analyst reports. The pattern of two downgrades against two maintained positive ratings and one neutral maintenance creates a mixed but marginally deteriorating consensus picture. Two of the five most recent actions represent downgrades, suggesting growing caution among analysts regarding PG's near-term return potential at current valuation levels.